Literature DB >> 8336662

[Current data on the antibiotic sensitivity of Streptococcus pneumoniae (Pneumococcus). The significance of penicillin resistant isolates].

R R Reinert1, R Lütticken, A Kaufhold.   

Abstract

Antibiotic-resistant pneumococci, including strains resistant to penicillin, are being isolated with increasing frequency also in Europe. Therefore, we studied the antibiotic sensitivity to penicillin, erythromycin, chloramphenicol, tetracycline, ofloxacin, and ciprofloxacin in 131 strains of Streptococcus pneumoniae; most of them were isolated from patients with systemic infections. A reduced susceptibility to penicillin was found in 7.6% (n = 10) of the Streptococcus pneumoniae strains. For the first time in Germany, in the present investigation two pneumococcal strains highly resistant to penicillin were isolated (minimal inhibitory concentration [MIC] values > or = 2 mg/l). These strains exhibited high MIC values against various cephalosporins as well. 10.7% of all pneumococci were resistant to tetracycline, resistance to erythromycin was found in 3.8% of the isolates. The emergence of pneumococci in Germany with reduced susceptibility to penicillin underscores the importance to include alternative drugs in sensitivity testing of pneumococci involved in systemic infections. Depending on the localization of the infection, parenteral third generation cephalosporins, glycopeptides and quinolone derivatives are primarily adequate in the treatment of infections caused by penicillin-resistant pneumococci.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8336662

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  6 in total

1.  Prevalence of antimicrobial resistance of Streptococcus pneumoniae in southwest Germany as determined by the E test.

Authors:  J Abb; H Breuninger; M Kommerell
Journal:  Eur J Epidemiol       Date:  1994-10       Impact factor: 8.082

2.  Antibiotic sensitivity of Streptococcus pneumoniae isolated from normally sterile body sites: first results of a multicenter study in Germany.

Authors:  R R Reinert; A Queck; A Kaufhold; M Kresken; R Lütticken
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

3.  In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.

Authors:  R R Reinert; A Bryskier; R Lütticken
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

4.  [Antibiotic sensitivity of important pathogens of bacterial respiratory tract infections in Northeast Germany].

Authors:  O Fierek; P Hinniger; B Panzig
Journal:  Med Klin (Munich)       Date:  1998-11-15

5.  [Community-acquired respiratory tract infections. Current data on the efficacy of various classes of antibiotics and antibiotic resistance of the main prevalent bacteria species].

Authors:  R Marre; M Trautmann
Journal:  Med Klin (Munich)       Date:  1999-11-15

6.  Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008.

Authors:  Matthias Imöhl; Ralf René Reinert; Christina Mutscher; Mark van der Linden
Journal:  BMC Microbiol       Date:  2010-11-25       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.